Latest Patents News

Power Minerals has signed a non-binding Term Sheet with Summit Explore to jointly develop the Salta Lithium Project in Argentina, aiming to deploy cutting-edge direct lithium extraction technology across multiple salars.

Energy Technologies Limited, via its subsidiary Cogenic, has acquired Maradin Ltd’s laser optical engineering IP portfolio, positioning itself at the forefront of laser projection technology for AR, VR, and defence applications.

Calix Limited has secured a two-year toll processing agreement with Green360 Technologies to produce calcined clay for low-carbon cement, leveraging existing capacity without capital outlay. This partnership aims to advance sustainable cement production while potentially generating several million dollars in annual revenue for Calix.

Sentinel Metals has reached a pivotal regulatory milestone as its Columbia Gold-Silver Project’s exploration amendment enters the public comment phase, paving the way for maiden drilling expected in April 2026.

Cleo Diagnostics has expanded its ovarian cancer biomarker panel from five to eight markers, enhancing test reliability and gearing up for FDA submission. A manufacturing deal is imminent, setting the stage for commercial rollout.

AdAlta Limited has been granted a key Canadian patent for its anti-fibrotic drug AD-214, completing its composition of matter protection across all major commercial markets. This milestone strengthens the company’s intellectual property portfolio and underpins its commercial strategy for AD-214.

Advanced Energy Minerals is ramping up production capacity at its Quebec plant, leveraging patented low-cost technology and renewable energy to meet booming global demand for high purity alumina.

Recce Pharmaceuticals is progressing its Phase 3 clinical trial of RECCE 327, a novel synthetic antibiotic targeting multidrug-resistant infections, with interim data from Indonesia supporting registration plans across ASEAN by 2026.

Image Resources NL has extended its prepayment facility term to December 2026 and negotiated a six-month repayment holiday to ease cashflow pressures amid a soft mineral sands market.

Imricor Medical Systems has filed a Form 10 registration with the U.S. SEC, marking its transition to a U.S. reporting company amid ongoing FDA clearances and clinical trials. This move signals a significant step in its early commercialisation of MRI-guided cardiac ablation technology.

Hazer Group has inked a non-binding graphite offtake agreement with Green Steel of WA, marking a significant step in supplying low-emission steel production with up to 85,000 tonnes over 10 years.

EBR Systems marked a pivotal transition in 2025 with FDA approval of its WiSE CRT System and the initiation of U.S. commercial implants, generating $1.6 million in revenue. Despite this progress, the company reported a net loss of $48.8 million and completed a significant capital raise to support ongoing growth.